Skip to main content

Detection of SARS-CoV-2 Armored RNA in Global Interlaboratory Harmonization Study

Whitepapers

In the COVID-19 pandemic, researchers needed reliable access to control material for developing, validating, and running diagnostic tests. A study run at 14 labs around the world shows that bacteriophage-protected (Armored) synthetic controls, which can be more easily distributed at the start of an outbreak, perform comparably to inactive virus.

Thumbnail for detection of sars-cov-2 armored rna whitepaper